Showing 641-650 of 8588 results for "".
ICD-10: When the Rubber Meets the Road
https://practicaldermatology.com/topics/practice-management/icd-10-when-the-rubber-meets-the-road/18632/When plans to move to ICD-10 were first announced, providers expressed concerns about potential logistical concerns with the new coding system. However, now that the new system is in regular use, Leon Kircik, MD said health claim denial rates have been lower than expected and the transition has beenOnline Reputation Management Update
https://practicaldermatology.com/topics/practice-management/online-reputation-management-update/18658/Protecting your online reputation is crucial to your digital marketing success. If you think it's all about spotting and hiding bad reviews, you're wrong. Learn how to build and protect a stellar online reputation for your dermatology practice and how it will actually boost SEO. The Ekwa Marketing tAtopic Dermatitis Journal Club: AD Guidelines May Represent a ‘Paradigm Shift’ in Care
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/atopic-derm-journal-club-ad-guidelines-may-represent-a-paradigm-shift-in-care/24075/In the first video of this series, Derek Chu, MD and Peter Lio, MD talk about new atopic dermatitis (AD) guidelines from the American Academy of Allergy, Asthma and Immunology Joint Task Force. These guidelines potentially represent a reshaping of the approach to AD care and understanding, accordingDermWireTV: ASDS Meeting Highlights; Daxxify Data; PA Week
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-asds-meeting-highlights-daxxify-data-pa-week/20147/ASDS speakers address aesthetic advancements, skin cancer, and DEI with Joel L. Cohen, MD, Sherrif Ibrahim, MD, and Jeanine Downie, MD. On the heels of FDA approval of Revance’s Daxxify, data published in the Aesthetic Surgery Journal demonstrate the efficacy of DaxibotulinumtoxinA for patients of dSocial media marketing trends for 2022 and beyond
https://practicaldermatology.com/topics/practice-management/social-media-marketing-trends-for-2022-and-beyond/20095/Social media is no longer the new frontier in digital marketing. It is a vital part of daily life for much of your audience. That means it is an indispensable part of a good marketing strategy for your dermatology practice. This short video from Ekwa Marketing (www.ekwa.com) covers the latest trendsScientifically Speaking: Managing Hair Loss Beyond PRP
https://practicaldermatology.com/series/scientifically-speaking/cientifically-speaking-managing-hair-loss-beyond-prp/20035/From documentary photographs to the potential for exosomes and the role of prescription therapies, many hot topics have emerged in the field of hair restoration. Glynis Ablon, MD and Jeffrey Rapaport, MD talk to host Joel L. Cohen, MD about clinical considerations beyond PRP.Scientifically Speaking: New Directions in Acne Management, Part 2
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-2/19950/From the optimal, safe use of isotretinoin to the proper role for systemic antibiotics and beyond, there are multiple areas of systemic acne care that deserve attention. In the second of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD aDermWireTV: Sun's PsO Impact Survey, Dermatology.com Expansion, More
https://practicaldermatology.com/topics/practice-management/dermwiretv-suns-pso-impact-survey-dermatologycom-expansion-more/19744/A Sun Pharma survey finds up to 44% of moderate-to-severe psoriasis patients often or sometimes feel humiliated by the appearance of plaques. Patients report effects on intimacy and relationships. Ortho Dermatologics adds telemedicine and new products to Dermatology.com. South Beach Symposium facultDermWire TV: Merz Reorganizes; Amzeeq Approved; Restoration Merges with Venus Concept
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-merz-reorganizes-amzeeq-approved-restoration-merges-with-venus-concept/19694/Bob Rhatigan, newly appointed Global Chief Executive Officer of Merz Aesthetics, speaks about Merz reorganization. Amzeeq topical foam (Foamix Pharmaceuticals) approved for inflammatory, non-nodular, moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older. FDA acTalking to Patients: Men v. Women
https://practicaldermatology.com/topics/practice-management/talking-to-patients-men-v-women/18693/Every patient is unique, but aesthetic physicians may need to tailor their communication style based on the patient's sex. It's also essential to convey to men that you understand the male aesthetic and how their treatment goals may differ from the typical woman's.